Alphatec Holdings, Inc. reported a recent operating update highlighting its ongoing integration of the InformatiX platform with a broad product portfolio targeting spine surgery. The company continues to expand its direct and independent sales network in the U.S., supporting sustained revenue growth driven by surgeon adoption and account penetration. Recent refinancing through a $175 million term loan and $125 million revolving credit facility with JPMorgan replaced prior credit lines, improving liquidity but maintaining substantial net debt. Litigation risks and continued challenges in profitability remain material considerations. Growth opportunities stem from advances in minimally invasive procedures and imaging technology integration, while regulatory and competitive pressures persist.